PUT - SPRINTER OPEN END - FRESENIUS MEDICAL CARE Stock

Certificat

DE000VU4WSV2

Market Closed - Deutsche Boerse AG 13:40:17 2024-06-04 EDT
11.02 EUR -0.09% Intraday chart for PUT - SPRINTER OPEN END - FRESENIUS MEDICAL CARE
Current month-0.54%
1 month-8.70%
Date Price Change
24-06-04 11.02 -0.09%
24-06-03 11.03 -0.45%
24-05-31 11.08 -0.36%
24-05-30 11.12 -5.84%
24-05-29 11.81 +8.45%

Delayed Quote Deutsche Boerse AG

Last update June 04, 2024 at 01:40 pm

More quotes

Static data

Product typeKnock-Out without Stop Loss
Buy / SellPUT
Underlying FRESENIUS MEDICAL CARE AG
IssuerLogo Issuer Vontobel Vontobel
WKN VU4WSV
ISINDE000VU4WSV2
Date issued 2023-03-16
Strike 50.07
Maturity Unlimited
Parity 1 : 1
Emission price 16.07
Emission volume N/A
Settlement cash
Currency EUR

Technical Indicators

Highest since issue 20.15
Lowest since issue 1.76

Company Profile

Fresenius Medical Care AG, formerly Fresenius Medical Care AG & Co. KGaA is a Germany-based Company, which is a kidney dialysis institute. The Company provides dialysis care and related services to persons suffering from end-stage renal disease (ESRD), as well as other healthcare services. The Company also develops and manufactures a wide variety of health care products, which includes dialysis and non-dialysis products. Its dialysis products include hemodialysis machines, peritoneal cyclers, dialyzers, peritoneal solutions and granulates, bloodlines, renal pharmaceuticals and systems for water treatment. Its non-dialysis products include acute cardiopulmonary and apheresis products. The Company supplies dialysis clinics it owns, operates or manages with a broad range of products, and sells dialysis products to other dialysis service providers.
Sector
-
More about the company

Ratings for Fresenius Medical Care AG

Trading Rating
Investor Rating
ESG Refinitiv
A-
More Ratings

Consensus: Fresenius Medical Care AG

Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
19
Last Close Price
39.14 EUR
Average target price
39.97 EUR
Spread / Average Target
+2.13%
Consensus